nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—ovarian cancer	0.422	1	CbGaD
Posaconazole—ABCB1—Topotecan—ovarian cancer	0.073	0.221	CbGbCtD
Posaconazole—ABCB1—Vinorelbine—ovarian cancer	0.0514	0.156	CbGbCtD
Posaconazole—CYP3A4—Topotecan—ovarian cancer	0.0437	0.133	CbGbCtD
Posaconazole—ABCB1—Paclitaxel—ovarian cancer	0.0361	0.11	CbGbCtD
Posaconazole—CYP3A4—Vinorelbine—ovarian cancer	0.0308	0.0935	CbGbCtD
Posaconazole—ABCB1—Docetaxel—ovarian cancer	0.0261	0.0792	CbGbCtD
Posaconazole—CYP3A4—Paclitaxel—ovarian cancer	0.0216	0.0657	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—ovarian cancer	0.0195	0.0591	CbGbCtD
Posaconazole—CYP3A4—Docetaxel—ovarian cancer	0.0156	0.0475	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—ovarian cancer	0.0117	0.0354	CbGbCtD
Posaconazole—Ketoconazole—CYP1B1—ovarian cancer	0.00158	0.566	CrCbGaD
Posaconazole—Itraconazole—ABCB1—ovarian cancer	0.000756	0.271	CrCbGaD
Posaconazole—Ketoconazole—ABCB1—ovarian cancer	0.000453	0.162	CrCbGaD
Posaconazole—Dry mouth—Docetaxel—ovarian cancer	7.78e-05	0.000317	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Doxorubicin—ovarian cancer	7.78e-05	0.000317	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	7.77e-05	0.000316	CcSEcCtD
Posaconazole—Fatigue—Paclitaxel—ovarian cancer	7.76e-05	0.000316	CcSEcCtD
Posaconazole—Pollakiuria—Doxorubicin—ovarian cancer	7.73e-05	0.000315	CcSEcCtD
Posaconazole—Pain—Paclitaxel—ovarian cancer	7.69e-05	0.000313	CcSEcCtD
Posaconazole—Constipation—Paclitaxel—ovarian cancer	7.69e-05	0.000313	CcSEcCtD
Posaconazole—Haematuria—Epirubicin—ovarian cancer	7.69e-05	0.000313	CcSEcCtD
Posaconazole—Confusional state—Docetaxel—ovarian cancer	7.69e-05	0.000313	CcSEcCtD
Posaconazole—Hepatobiliary disease—Epirubicin—ovarian cancer	7.63e-05	0.00031	CcSEcCtD
Posaconazole—Oedema—Docetaxel—ovarian cancer	7.62e-05	0.00031	CcSEcCtD
Posaconazole—Weight increased—Doxorubicin—ovarian cancer	7.62e-05	0.00031	CcSEcCtD
Posaconazole—Epistaxis—Epirubicin—ovarian cancer	7.61e-05	0.00031	CcSEcCtD
Posaconazole—Infection—Docetaxel—ovarian cancer	7.58e-05	0.000308	CcSEcCtD
Posaconazole—Weight decreased—Doxorubicin—ovarian cancer	7.57e-05	0.000308	CcSEcCtD
Posaconazole—Sinusitis—Epirubicin—ovarian cancer	7.57e-05	0.000308	CcSEcCtD
Posaconazole—Hyperglycaemia—Doxorubicin—ovarian cancer	7.55e-05	0.000307	CcSEcCtD
Posaconazole—Agranulocytosis—Epirubicin—ovarian cancer	7.53e-05	0.000306	CcSEcCtD
Posaconazole—Pneumonia—Doxorubicin—ovarian cancer	7.5e-05	0.000306	CcSEcCtD
Posaconazole—Shock—Docetaxel—ovarian cancer	7.5e-05	0.000305	CcSEcCtD
Posaconazole—Nervous system disorder—Docetaxel—ovarian cancer	7.48e-05	0.000304	CcSEcCtD
Posaconazole—Thrombocytopenia—Docetaxel—ovarian cancer	7.47e-05	0.000304	CcSEcCtD
Posaconazole—Infestation NOS—Doxorubicin—ovarian cancer	7.46e-05	0.000304	CcSEcCtD
Posaconazole—Infestation—Doxorubicin—ovarian cancer	7.46e-05	0.000304	CcSEcCtD
Posaconazole—Tachycardia—Docetaxel—ovarian cancer	7.44e-05	0.000303	CcSEcCtD
Posaconazole—Feeling abnormal—Paclitaxel—ovarian cancer	7.41e-05	0.000302	CcSEcCtD
Posaconazole—Skin disorder—Docetaxel—ovarian cancer	7.41e-05	0.000302	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.4e-05	0.000301	CcSEcCtD
Posaconazole—Bradycardia—Epirubicin—ovarian cancer	7.37e-05	0.0003	CcSEcCtD
Posaconazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.36e-05	0.000299	CcSEcCtD
Posaconazole—Renal failure—Doxorubicin—ovarian cancer	7.33e-05	0.000299	CcSEcCtD
Posaconazole—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.31e-05	0.000298	CcSEcCtD
Posaconazole—Haemoglobin—Epirubicin—ovarian cancer	7.28e-05	0.000296	CcSEcCtD
Posaconazole—Stomatitis—Doxorubicin—ovarian cancer	7.27e-05	0.000296	CcSEcCtD
Posaconazole—Jaundice—Doxorubicin—ovarian cancer	7.27e-05	0.000296	CcSEcCtD
Posaconazole—Anorexia—Docetaxel—ovarian cancer	7.27e-05	0.000296	CcSEcCtD
Posaconazole—Rhinitis—Epirubicin—ovarian cancer	7.26e-05	0.000295	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—ovarian cancer	7.25e-05	0.000295	CcSEcCtD
Posaconazole—Conjunctivitis—Doxorubicin—ovarian cancer	7.25e-05	0.000295	CcSEcCtD
Posaconazole—Haemorrhage—Epirubicin—ovarian cancer	7.24e-05	0.000295	CcSEcCtD
Posaconazole—Hepatitis—Epirubicin—ovarian cancer	7.24e-05	0.000295	CcSEcCtD
Posaconazole—Hypoaesthesia—Epirubicin—ovarian cancer	7.2e-05	0.000293	CcSEcCtD
Posaconazole—Pharyngitis—Epirubicin—ovarian cancer	7.18e-05	0.000292	CcSEcCtD
Posaconazole—Urinary tract disorder—Epirubicin—ovarian cancer	7.15e-05	0.000291	CcSEcCtD
Posaconazole—Urticaria—Paclitaxel—ovarian cancer	7.15e-05	0.000291	CcSEcCtD
Posaconazole—Oedema peripheral—Epirubicin—ovarian cancer	7.13e-05	0.00029	CcSEcCtD
Posaconazole—Hypotension—Docetaxel—ovarian cancer	7.12e-05	0.00029	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—ovarian cancer	7.11e-05	0.00029	CcSEcCtD
Posaconazole—Connective tissue disorder—Epirubicin—ovarian cancer	7.11e-05	0.00029	CcSEcCtD
Posaconazole—Abdominal pain—Paclitaxel—ovarian cancer	7.11e-05	0.000289	CcSEcCtD
Posaconazole—Body temperature increased—Paclitaxel—ovarian cancer	7.11e-05	0.000289	CcSEcCtD
Posaconazole—Urethral disorder—Epirubicin—ovarian cancer	7.1e-05	0.000289	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—ovarian cancer	7.06e-05	0.000287	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—ovarian cancer	7.04e-05	0.000286	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—ovarian cancer	7e-05	0.000285	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—ovarian cancer	6.96e-05	0.000283	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.95e-05	0.000283	CcSEcCtD
Posaconazole—Insomnia—Docetaxel—ovarian cancer	6.9e-05	0.000281	CcSEcCtD
Posaconazole—Paraesthesia—Docetaxel—ovarian cancer	6.85e-05	0.000279	CcSEcCtD
Posaconazole—Erythema multiforme—Epirubicin—ovarian cancer	6.84e-05	0.000279	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—ovarian cancer	6.82e-05	0.000278	CcSEcCtD
Posaconazole—Dyspnoea—Docetaxel—ovarian cancer	6.8e-05	0.000277	CcSEcCtD
Posaconazole—Somnolence—Docetaxel—ovarian cancer	6.78e-05	0.000276	CcSEcCtD
Posaconazole—Eye disorder—Epirubicin—ovarian cancer	6.76e-05	0.000275	CcSEcCtD
Posaconazole—Tinnitus—Epirubicin—ovarian cancer	6.75e-05	0.000275	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—ovarian cancer	6.73e-05	0.000274	CcSEcCtD
Posaconazole—Flushing—Epirubicin—ovarian cancer	6.72e-05	0.000273	CcSEcCtD
Posaconazole—Cardiac disorder—Epirubicin—ovarian cancer	6.72e-05	0.000273	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—ovarian cancer	6.71e-05	0.000273	CcSEcCtD
Posaconazole—Dyspepsia—Docetaxel—ovarian cancer	6.71e-05	0.000273	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—ovarian cancer	6.7e-05	0.000273	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—ovarian cancer	6.7e-05	0.000273	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—ovarian cancer	6.66e-05	0.000271	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—ovarian cancer	6.65e-05	0.000271	CcSEcCtD
Posaconazole—Decreased appetite—Docetaxel—ovarian cancer	6.63e-05	0.00027	CcSEcCtD
Posaconazole—Hypersensitivity—Paclitaxel—ovarian cancer	6.63e-05	0.00027	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—ovarian cancer	6.61e-05	0.000269	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—ovarian cancer	6.6e-05	0.000269	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	6.58e-05	0.000268	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—ovarian cancer	6.58e-05	0.000268	CcSEcCtD
Posaconazole—Fatigue—Docetaxel—ovarian cancer	6.57e-05	0.000268	CcSEcCtD
Posaconazole—Angiopathy—Epirubicin—ovarian cancer	6.57e-05	0.000267	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—ovarian cancer	6.57e-05	0.000267	CcSEcCtD
Posaconazole—Immune system disorder—Epirubicin—ovarian cancer	6.54e-05	0.000266	CcSEcCtD
Posaconazole—Mediastinal disorder—Epirubicin—ovarian cancer	6.52e-05	0.000266	CcSEcCtD
Posaconazole—Pain—Docetaxel—ovarian cancer	6.52e-05	0.000265	CcSEcCtD
Posaconazole—Constipation—Docetaxel—ovarian cancer	6.52e-05	0.000265	CcSEcCtD
Posaconazole—Chills—Epirubicin—ovarian cancer	6.5e-05	0.000264	CcSEcCtD
Posaconazole—Arrhythmia—Epirubicin—ovarian cancer	6.47e-05	0.000263	CcSEcCtD
Posaconazole—Asthenia—Paclitaxel—ovarian cancer	6.45e-05	0.000263	CcSEcCtD
Posaconazole—Alopecia—Epirubicin—ovarian cancer	6.4e-05	0.00026	CcSEcCtD
Posaconazole—Pruritus—Paclitaxel—ovarian cancer	6.36e-05	0.000259	CcSEcCtD
Posaconazole—Mental disorder—Epirubicin—ovarian cancer	6.34e-05	0.000258	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—ovarian cancer	6.33e-05	0.000258	CcSEcCtD
Posaconazole—Erythema—Epirubicin—ovarian cancer	6.3e-05	0.000257	CcSEcCtD
Posaconazole—Malnutrition—Epirubicin—ovarian cancer	6.3e-05	0.000257	CcSEcCtD
Posaconazole—Feeling abnormal—Docetaxel—ovarian cancer	6.28e-05	0.000256	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—ovarian cancer	6.26e-05	0.000255	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—ovarian cancer	6.24e-05	0.000254	CcSEcCtD
Posaconazole—Gastrointestinal pain—Docetaxel—ovarian cancer	6.23e-05	0.000254	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—ovarian cancer	6.22e-05	0.000253	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—ovarian cancer	6.22e-05	0.000253	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—ovarian cancer	6.21e-05	0.000253	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—ovarian cancer	6.17e-05	0.000251	CcSEcCtD
Posaconazole—Diarrhoea—Paclitaxel—ovarian cancer	6.15e-05	0.000251	CcSEcCtD
Posaconazole—Back pain—Epirubicin—ovarian cancer	6.1e-05	0.000248	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—ovarian cancer	6.08e-05	0.000247	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—ovarian cancer	6.06e-05	0.000247	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—ovarian cancer	6.05e-05	0.000246	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—ovarian cancer	6.04e-05	0.000246	CcSEcCtD
Posaconazole—Body temperature increased—Docetaxel—ovarian cancer	6.03e-05	0.000245	CcSEcCtD
Posaconazole—Abdominal pain—Docetaxel—ovarian cancer	6.03e-05	0.000245	CcSEcCtD
Posaconazole—Chills—Doxorubicin—ovarian cancer	6.01e-05	0.000245	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—ovarian cancer	5.98e-05	0.000244	CcSEcCtD
Posaconazole—Dizziness—Paclitaxel—ovarian cancer	5.95e-05	0.000242	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—ovarian cancer	5.94e-05	0.000242	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—ovarian cancer	5.92e-05	0.000241	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—ovarian cancer	5.87e-05	0.000239	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—ovarian cancer	5.85e-05	0.000238	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—ovarian cancer	5.83e-05	0.000237	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—ovarian cancer	5.83e-05	0.000237	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—ovarian cancer	5.82e-05	0.000237	CcSEcCtD
Posaconazole—Agitation—Epirubicin—ovarian cancer	5.79e-05	0.000236	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—ovarian cancer	5.75e-05	0.000234	CcSEcCtD
Posaconazole—Vomiting—Paclitaxel—ovarian cancer	5.72e-05	0.000233	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—ovarian cancer	5.71e-05	0.000232	CcSEcCtD
Posaconazole—Malaise—Epirubicin—ovarian cancer	5.68e-05	0.000231	CcSEcCtD
Posaconazole—Rash—Paclitaxel—ovarian cancer	5.67e-05	0.000231	CcSEcCtD
Posaconazole—Dermatitis—Paclitaxel—ovarian cancer	5.67e-05	0.000231	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—ovarian cancer	5.66e-05	0.00023	CcSEcCtD
Posaconazole—Syncope—Epirubicin—ovarian cancer	5.65e-05	0.00023	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—ovarian cancer	5.64e-05	0.00023	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—ovarian cancer	5.64e-05	0.00023	CcSEcCtD
Posaconazole—Headache—Paclitaxel—ovarian cancer	5.64e-05	0.000229	CcSEcCtD
Posaconazole—Hypersensitivity—Docetaxel—ovarian cancer	5.62e-05	0.000229	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—ovarian cancer	5.61e-05	0.000228	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—ovarian cancer	5.54e-05	0.000225	CcSEcCtD
Posaconazole—Cough—Epirubicin—ovarian cancer	5.5e-05	0.000224	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—ovarian cancer	5.5e-05	0.000224	CcSEcCtD
Posaconazole—Asthenia—Docetaxel—ovarian cancer	5.47e-05	0.000223	CcSEcCtD
Posaconazole—Convulsion—Epirubicin—ovarian cancer	5.46e-05	0.000222	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—ovarian cancer	5.44e-05	0.000221	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—ovarian cancer	5.41e-05	0.00022	CcSEcCtD
Posaconazole—Pruritus—Docetaxel—ovarian cancer	5.39e-05	0.00022	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—ovarian cancer	5.39e-05	0.000219	CcSEcCtD
Posaconazole—Chest pain—Epirubicin—ovarian cancer	5.36e-05	0.000218	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—ovarian cancer	5.36e-05	0.000218	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—ovarian cancer	5.36e-05	0.000218	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—ovarian cancer	5.36e-05	0.000218	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—ovarian cancer	5.35e-05	0.000218	CcSEcCtD
Posaconazole—Nausea—Paclitaxel—ovarian cancer	5.34e-05	0.000218	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.33e-05	0.000217	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—ovarian cancer	5.3e-05	0.000216	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—ovarian cancer	5.26e-05	0.000214	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—ovarian cancer	5.25e-05	0.000214	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—ovarian cancer	5.24e-05	0.000213	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—ovarian cancer	5.23e-05	0.000213	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—ovarian cancer	5.22e-05	0.000212	CcSEcCtD
Posaconazole—Diarrhoea—Docetaxel—ovarian cancer	5.22e-05	0.000212	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—ovarian cancer	5.19e-05	0.000211	CcSEcCtD
Posaconazole—Oedema—Epirubicin—ovarian cancer	5.14e-05	0.000209	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—ovarian cancer	5.12e-05	0.000209	CcSEcCtD
Posaconazole—Infection—Epirubicin—ovarian cancer	5.11e-05	0.000208	CcSEcCtD
Posaconazole—Cough—Doxorubicin—ovarian cancer	5.09e-05	0.000207	CcSEcCtD
Posaconazole—Shock—Epirubicin—ovarian cancer	5.06e-05	0.000206	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—ovarian cancer	5.05e-05	0.000206	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—ovarian cancer	5.04e-05	0.000205	CcSEcCtD
Posaconazole—Dizziness—Docetaxel—ovarian cancer	5.04e-05	0.000205	CcSEcCtD
Posaconazole—Thrombocytopenia—Epirubicin—ovarian cancer	5.04e-05	0.000205	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—ovarian cancer	5.03e-05	0.000205	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—ovarian cancer	5.02e-05	0.000204	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—ovarian cancer	5e-05	0.000203	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—ovarian cancer	4.97e-05	0.000202	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—ovarian cancer	4.96e-05	0.000202	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—ovarian cancer	4.96e-05	0.000202	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—ovarian cancer	4.96e-05	0.000202	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—ovarian cancer	4.95e-05	0.000201	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.93e-05	0.000201	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—ovarian cancer	4.9e-05	0.0002	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—ovarian cancer	4.9e-05	0.0002	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—ovarian cancer	4.85e-05	0.000198	CcSEcCtD
Posaconazole—Vomiting—Docetaxel—ovarian cancer	4.85e-05	0.000197	CcSEcCtD
Posaconazole—Rash—Docetaxel—ovarian cancer	4.81e-05	0.000196	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—ovarian cancer	4.81e-05	0.000196	CcSEcCtD
Posaconazole—Dermatitis—Docetaxel—ovarian cancer	4.8e-05	0.000196	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—ovarian cancer	4.8e-05	0.000195	CcSEcCtD
Posaconazole—Headache—Docetaxel—ovarian cancer	4.78e-05	0.000194	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—ovarian cancer	4.76e-05	0.000194	CcSEcCtD
Posaconazole—Infection—Doxorubicin—ovarian cancer	4.73e-05	0.000192	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.69e-05	0.000191	CcSEcCtD
Posaconazole—Shock—Doxorubicin—ovarian cancer	4.68e-05	0.000191	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—ovarian cancer	4.67e-05	0.00019	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—ovarian cancer	4.66e-05	0.00019	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—ovarian cancer	4.65e-05	0.000189	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—ovarian cancer	4.64e-05	0.000189	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—ovarian cancer	4.62e-05	0.000188	CcSEcCtD
Posaconazole—Paraesthesia—Epirubicin—ovarian cancer	4.62e-05	0.000188	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—ovarian cancer	4.6e-05	0.000187	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—ovarian cancer	4.59e-05	0.000187	CcSEcCtD
Posaconazole—Somnolence—Epirubicin—ovarian cancer	4.57e-05	0.000186	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—ovarian cancer	4.54e-05	0.000185	CcSEcCtD
Posaconazole—Nausea—Docetaxel—ovarian cancer	4.53e-05	0.000184	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—ovarian cancer	4.53e-05	0.000184	CcSEcCtD
Posaconazole—Decreased appetite—Epirubicin—ovarian cancer	4.47e-05	0.000182	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—ovarian cancer	4.45e-05	0.000181	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.44e-05	0.000181	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—ovarian cancer	4.43e-05	0.000181	CcSEcCtD
Posaconazole—Pain—Epirubicin—ovarian cancer	4.4e-05	0.000179	CcSEcCtD
Posaconazole—Constipation—Epirubicin—ovarian cancer	4.4e-05	0.000179	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.34e-05	0.000176	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—ovarian cancer	4.3e-05	0.000175	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—ovarian cancer	4.27e-05	0.000174	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—ovarian cancer	4.24e-05	0.000173	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—ovarian cancer	4.24e-05	0.000173	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—ovarian cancer	4.23e-05	0.000172	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—ovarian cancer	4.21e-05	0.000171	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—ovarian cancer	4.19e-05	0.000171	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—ovarian cancer	4.14e-05	0.000168	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.11e-05	0.000167	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—ovarian cancer	4.1e-05	0.000167	CcSEcCtD
Posaconazole—Urticaria—Epirubicin—ovarian cancer	4.09e-05	0.000166	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—ovarian cancer	4.07e-05	0.000166	CcSEcCtD
Posaconazole—Pain—Doxorubicin—ovarian cancer	4.07e-05	0.000166	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—ovarian cancer	4.07e-05	0.000166	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—ovarian cancer	4.07e-05	0.000166	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—ovarian cancer	3.92e-05	0.00016	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.89e-05	0.000158	CcSEcCtD
Posaconazole—Hypersensitivity—Epirubicin—ovarian cancer	3.79e-05	0.000154	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—ovarian cancer	3.78e-05	0.000154	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—ovarian cancer	3.76e-05	0.000153	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—ovarian cancer	3.76e-05	0.000153	CcSEcCtD
Posaconazole—Asthenia—Epirubicin—ovarian cancer	3.69e-05	0.00015	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—ovarian cancer	3.64e-05	0.000148	CcSEcCtD
Posaconazole—Diarrhoea—Epirubicin—ovarian cancer	3.52e-05	0.000143	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—ovarian cancer	3.51e-05	0.000143	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—ovarian cancer	3.41e-05	0.000139	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—ovarian cancer	3.4e-05	0.000138	CcSEcCtD
Posaconazole—Pruritus—Doxorubicin—ovarian cancer	3.37e-05	0.000137	CcSEcCtD
Posaconazole—Vomiting—Epirubicin—ovarian cancer	3.27e-05	0.000133	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—ovarian cancer	3.26e-05	0.000133	CcSEcCtD
Posaconazole—Rash—Epirubicin—ovarian cancer	3.24e-05	0.000132	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—ovarian cancer	3.24e-05	0.000132	CcSEcCtD
Posaconazole—Headache—Epirubicin—ovarian cancer	3.22e-05	0.000131	CcSEcCtD
Posaconazole—Dizziness—Doxorubicin—ovarian cancer	3.15e-05	0.000128	CcSEcCtD
Posaconazole—Nausea—Epirubicin—ovarian cancer	3.05e-05	0.000124	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—ovarian cancer	3.03e-05	0.000123	CcSEcCtD
Posaconazole—Rash—Doxorubicin—ovarian cancer	3e-05	0.000122	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—ovarian cancer	3e-05	0.000122	CcSEcCtD
Posaconazole—Headache—Doxorubicin—ovarian cancer	2.98e-05	0.000121	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—ovarian cancer	2.83e-05	0.000115	CcSEcCtD
